News | April 28, 2010

FDA Warns Of Several Faulty External Defibrillators

April 28, 2010 – About 280,000 external defibrillators used worldwide in health care facilities and public places may malfunction during attempts to rescue people in sudden cardiac arrest, the U.S. Food and Drug Administration (FDA) warned this week.

Faulty components in defibrillators manufactured by Cardiac Science Corp. of Bothell, Wash., may cause the devices to fail to properly deliver a shock. In addition to failure to deliver needed shocks, other problems with the affected models may include interruption of electrocardiography (ECG) analysis, failure to recognize electrode pads, and interference or background noise that makes the device unable to accurately analyze heart rhythm.

Recalled Models

The 14 affected models, which include automated and semi-automated devices, are:

• Powerheart models 9300A, 9300C, 9300D, 9300E, 9300P, 9390A and 9390E?

• CardioVive models 92531, 92532 and 92533?

• Nihon Kohden models 9200G and 9231 and?

• GE Responder models 2019198 and 2023440.

The FDA recommends hospitals, nursing homes and other high-risk settings obtain alternative external defibrillators and arrange for the repair or replacement of the affected defibrillators. If alternative external defibrillators are not immediately available, then FDA recommends continuing to use the affected devices if needed, because they may still deliver necessary therapy.

“The FDA is issuing this notice so that users can take the proper steps necessary to assure they have access to safe and effective defibrillators,” said Jeffrey Shuren, M.D., JD, director of the FDA’s Center for Devices and Radiological Health.

Cardiac Science recalled its Powerheart and CardioVive models, manufactured between August 2003 and August 2009, on Nov. 13, 2009. But the FDA has since learned that additional Cardiac Science models, two marketed under the Nihon Kohden name, and two marketed by GE Healthcare as GE Responder have similar problems.

Cardiac Science issued a software update for two of its Powerheart defibrillators in February 2010 and plans to issue similar software updates for other affected devices. However, FDA’s review of the updated software indicates that the software detects some, but not all, identified defects.

LIFEPAK 15 Recalled

A Class I recall recently announced is for Physio-Control’s Lifepak 15 Monitor/Defibrillator. These devices were manufactured between March 26 and Dec. 15, 2009 and distributed during the same time.
The reason for recall is a potential for the device to unexpectedly:

• Power off then on by itself.
• Power off then not turn on.
• Power off by itself requiring the operator to turn it back on.
• Stay powered on and not allow itself to be turned off.

Class 1 recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or

For more information: www.fda.gov/Safety/MedWatch/default.htm, www.physio-control-notices.com/LP15pcba

Related Content

wearable defibrillators prevent sudden cardiac death in pediatric patients
Feature | Sudden Cardiac Arrest| May 11, 2017
May 11, 2017 — A new study shows that the use of a wearable cardioverter defibrillator (WCD) is safe and effective in
Physio-Control Launches HeartSine samaritan PAD 360P Automated External Defibrillator in United States
Technology | Defibrillator Monitors| April 24, 2017
Physio-Control announced April 19 that the company’s HeartSine samaritan PAD 360P (SAM 360P) fully automatic external...
AEDs, automated external defibrillators, requirements, U.S. schools, JACC study
News | Defibrillator Monitors| March 30, 2017
Automated external defibrillators (AEDs) are associated with increased survival of sudden cardiac arrest when installed...
Philips, FDA, class I recall, HeartStart MRx Monitor/Defibrillator
News | Defibrillator Monitors| March 28, 2017
Philips and the U.S. Food and Drug Administration (FDA) announced the company has initiated a recall of its HeartStart...
Zoll, Hospital Wearable Defibrillator, HWD, FDA premarket approval
Technology | Defibrillator Monitors| March 10, 2017
Zoll Medical Corp. announced that the company’s Hospital Wearable Defibrillator (HWD) has been granted premarket...
LifePak, AED, sudden cardiac arrest, defibrillator, automatic external defibrillator

A Physio-Control LifePak CR Plus defibrillator shown in use during a hand-off to paramedics, who use larger, more sophisticated defibrillator-monitors (behind gloved paramedic).

Feature | Sudden Cardiac Arrest| September 28, 2016 | Allied Market Research
Automated external defibrillators (AED) are portable and lightweight devices used to deliver an electric shock throug
Zoll LifeVest wearable defibrillator, WEARIT-II Registry results, CardioStim EuroPace 2016
News | Defibrillator Monitors| June 21, 2016
Zoll Medical Corp. announced that patients experience a high one-year survival rate following use of the LifeVest...
Cath lab, clinical trial, clinical study, defibrillator monitors
News | December 16, 2014
A faster, coordinated emergency response in collaboration with hospital cardiac catheterization laboratories in each...
3-D Printing, Congenital heart, The Children's Hospital of Philadelphia (CHOP)
News | December 01, 2014
Physician-researchers from the Cardiac Center at The Children’s Hospital of Philadelphia (CHOP) presented new findings...
Overlay Init